Skip to main content
Log in

Optimization of the refolding of recombinant human granulocyte-macrophage colony-stimulating factor immobilized on affinity sorbent

  • Technology of Biopreparations
  • Published:
Applied Biochemistry and Microbiology Aims and scope Submit manuscript

Abstract

A method for the production and purification of biologically active recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF), expressed in Escherichia coli, has been developed. Washing of an inclusion body fraction which allows the removal of numerous ballast proteins and on-column refolding of rhGM-CSF are specific characteristics of the method. The refolding efficiency reached 70%; the purity of the preparation constituted 95%. The biological activity was similar to those of other recombinant hGM-CSF analogs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

APC:

antigen-presenting cells

GM-CSF:

granulocyte-macrophage colony-stimulating factor

DMSO:

dimethylsulphoxide

IEA:

immune enzyme assay

MTT:

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

OD:

optical density

PAAG:

polyacrylamide gel

PMSF:

phenilmethylsulfonyl fluoride

PCR:

polymerase chain reaction

rhGM:

CSF-human recombinant granulocyte-macrophage colony-stimulating factor

LB medium:

Luria-Bertani medium

IBs:

inclusion bodies

TNF:

tumor necrosis factor

EMEA:

European Agency for the Evaluation of Medicinal Products

IPTG:

isopropyl [beta]-D-1-thiogalactopyranoside

FDA:

Food and Drug Administration, United States

HEPES:

4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid

G-CSF:

granulocyte colony stimulating factor

M-CSF:

macrophage colony-stimulating factor

References

  1. Recchia, F., de Filippis, S., Torchio, P., Rea, S., Gulino, A., Quaglino, D., and Frati, L., Randomized trial of filgrastim vs. sequential filgrastim and molgramostim after dose-intensified carboplatin, cyclophosphamide, and etoposide: a phase I pilot study, Am. J. Clin. Oncol., 1997, vol. 20, no. 2, pp. 209–214.

    Article  CAS  PubMed  Google Scholar 

  2. Sylvester, R.K., Clinical applications of colony-stimulating factors: a historical perspective, Am. J. Health Syst. Pharm., 2002, vol. 59, pp. 6–12.

    Google Scholar 

  3. Waller, E.K., The role of sargramostim (rhGM-CSF) as immunotherapy, Oncologist, 2007, vol. 12, pp. 22–26.

    Article  CAS  PubMed  Google Scholar 

  4. Polovinkina, V.S. and Kosorukov, V.S., Recombinant rhGM-CSF in oncology, Ross. Bioterapevt. Zh., 2009, vol. 8, no. 1, pp. 29–39.

    Google Scholar 

  5. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines, J. Clin. Oncol., 1994, vol. 12, no. 11, pp. 2471–2508.

    Google Scholar 

  6. Baryshnikov, A.Yu., Principles and practice of cancer vaccinotherapy, Byull. SO RAMN, 2004, vol. 112, no. 2, pp. 59–63.

    Google Scholar 

  7. Malik, F., Delgado, C., Knusli, C., Irvine, A.E., Fisher, D., and Francis, G.E., Polyethylene glycol (PEG)-modified granulocyte-macrophage colonystimulating factor (GM-CSF) with conserved biological activity, Exp. Hematol., 1992, vol. 20, no. 8, pp. 1028–1035.

    CAS  PubMed  Google Scholar 

  8. Bai, L., Hu, Z., Wang, F., Xu, X., Xia, C., Jin, L., Li, J., and Gao, J., Generation of streptavidin-tagged human-granulocyte macrophage colony-stimulating factor fusion proteins, Nan. Fang Yi Ke Da Xue Xue Bao, 2012, vol. 32, no. 10, pp. 1389–1393.

    CAS  PubMed  Google Scholar 

  9. Wen, Q., Ma, L., Luo, W., Zhou, M.Q., He, D., Lin, Y., Wu, Z.Q., He, X.W., Wang, J.F., and Wang, X.N., Comparison of four methods for the purification and refolding of human interleukin-2-mouse granulocyte/macrophage colony-stimulating factor fusion protein, Biotechnol. Appl. Biochem., 2008, vol. 50, pp. 41–48.

    Article  CAS  PubMed  Google Scholar 

  10. Khasa, Y.P., Khushoo, A., Tapryal, S., and Mukherjee, K.J., Optimization of human granulocyte macrophage-colony stimulating factor (hGM-CSF) expression using asparaginase and xylanase gene’s signal sequences in Escherichia coli, Appl. Biochem. Biotechnol., 2011, vol. 165, no. 2, pp. 523–537.

    Article  CAS  PubMed  Google Scholar 

  11. Schwanke, R.C., Renard, G., Chies, J.M., Campos, M.M., Batista, E.L., Jr., Santos, D.S., and Basso, L.A., Molecular cloning, expression in Escherichia coli and production of bioactive homogeneous recombinant human granulocyte and macrophage colony stimulating factor, Int. J. Biol. Macromol., 2009, vol. 45, no. 2, pp. 97–102.

    Article  CAS  PubMed  Google Scholar 

  12. Srinivasa, K., Babu Srinivasa, K., Antony, A., Muthukumaran, T., and Meenakshisundaram, S., Construction of intein-mediated hGMCSF expression vector and its purification in Pichia pastoris, Prot. Expr. Purif., 2008, vol. 57, no. 2, pp. 201–205.

    Article  Google Scholar 

  13. James, E.A., Wang, C., Wang, Z., Reeves, R., Shin, J.H., Magnuson, N.S., and Lee, J.M., Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells, Prot. Expr. Purif., 2000, vol. 19, no. 1, pp. 131–138.

    Article  CAS  Google Scholar 

  14. Zhou, F., Zhou, F., Wang, M.L., Albert, H.H., Moore, P.H., and Zhu, Y.J., Efficient transient expression of human GM-CSF protein in Nicotiana benthamiana using potato virus X vector, Appl. Microbiol. Biotechnol., 2006, vol. 72, no. 4, pp. 756–762.

    Article  CAS  PubMed  Google Scholar 

  15. Vincentelli, R., Canaan, S., Campanacci, V., Valencia, C., Maurin, D., Frassinetti, F., Scappucini-Calvo, L., Bourne, Y., Cambillau, C., and Bignon, C., High-throughput automated refolding screening of inclusion bodies, Protein Sci., 2004, vol. 13, no. 10, pp. 2782–2792.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Gasparian, M.E., Ostapchenko, V.G., Schulga, A.A., Dolgikh, D.A., and Kirpichnikov, M.P., Expression, purification, and characterization of human enteropeptidase catalytic subunit in Escherichia coli, Prot. Expr. Purif., 2003, vol. 31, no. 1, pp. 133–139.

    Article  CAS  Google Scholar 

  17. Ujihara, M., Nomura, K., Yamada, O., Shibata, N., Kobayashi, M., and Takano, K., Granulocyte-macrophage colony-stimulating factor ensures macrophage survival and generation of the superoxide anion: a using a monocytic-differentiated HL60 subline, Free Radic. Biol. Med., 2001, vol. 31, no. 11, pp. 1396–1404.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. N. Kosobokova.

Additional information

Original Russian Text © E.N. Kosobokova, K.A. Skrypnik, M.V. Pinyugina, A.I. Shcherbakov, V.S. Kosorukov, 2013, published in Biotekhnologiya, 2013, No. 3, pp. 39–46.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kosobokova, E.N., Skrypnik, K.A., Pinyugina, M.V. et al. Optimization of the refolding of recombinant human granulocyte-macrophage colony-stimulating factor immobilized on affinity sorbent. Appl Biochem Microbiol 50, 773–779 (2014). https://doi.org/10.1134/S0003683814080031

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0003683814080031

Keywords

Navigation